10th Liquid Biopsy for Precision Oncology Summit

The 10th Liquid Biopsy for Precision Oncology Summit is the world’s leading annual meeting dedicated to advancing the science, clinical translation, and commercial adoption of liquid biopsy technologies in precision oncology. Now in its 10th anniversary year, this summit convenes pharma, biotech, diagnostics, academia, patient advocates and policy leaders to address translational, regulatory and reimbursement challenges that stand between scientific innovation and real-world implementation. The program spans the entire oncology drug development pipeline from discovery through clinical translation to regulatory approval and commercial adoption with a focus on emerging biomarkers such as ctDNA, MRD, multi-omic approaches, methylation profiling and novel analytes that are transforming earlier detection and personalised therapy strategies.

Participants can expect a dynamic agenda featuring plenary talks, focused content tracks and interactive workshops designed to define solutions that accelerate standardisation, evidence generation and global adoption of liquid biopsy testing. With sessions that examine translational science, regulatory pathways, reimbursement strategy and clinical adoption, the summit provides a powerful forum for networking, collaboration and cross-sector insight that drives progress in precision oncology diagnostics and therapies.